Dr. Lars E. Birgerson recently tendered to the board of directors his request for retirement from his current roles as the President and the chief medical officer of Adlai Nortye Ltd. (the Company), effective on July 2, 2024. Dr. Birgerson will continue to serve as a director of the Company. Dr. Kaiyang (Tom) Tang, currently a senior vice president and the global head of clinical operations of the Company, succeeded Dr. Birgerson as the President of Company, effective on July 2, 2024.

He ceased his responsibilities as a senior vice president and the global head of clinical operations of the Company to fully devote his time to the new role with effect from July 2, 2024. Dr. Lars E. Birgerson and Dr. Kaiyang (Tom) Tang have confirmed that there is no dispute or disagreement with the Company on any matter relating to the Company?s operations, policies, or practices.